Studying new antidepressants: If there were a light at the end of the tunnel, could we see it?

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 2, 2002, Pages 24-28

  Thase, Michael E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; LIMBITROL; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; HUMAN; META ANALYSIS; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; META-ANALYSIS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0036197482     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Clinical practice guideline number 5
2. Practice guideline for the treatment of patients with major depressive disorder
3. Can monoamine-based therapies be improved?
4. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
5. Onset of action of selective and multi-action antidepressants
6. Does mirtazapine have a more rapid onset than SSRIs?
7. How should efficacy be evaluated in randomized clinical trials of treatments for depression?
8. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database
9. A rating scale for depression
10. Characteristics of treatment-resistant depression
11. Placebo controls
12. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder
13. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline
14. Reemergence of sexual dysfunction in patients with major depressive disorder: Double blind comparison of nefazodone and sertraline
15. Venlafaxine and paroxetine in treatment-resistant depression: Double-blind, randomized comparison
16. Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo
17. MAOIs in the contemporary treatment of depression
18. The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy
19. Validity of clinical trials of antidepressants
20. Tranylcypromine versus imipramine in anergic bipolar depression
21. Systematic reviews and meta-analysis
22. The efficacy of selective serotonin reuptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants
23. Selective serotonin reuptake inhibitors: Meta-analysis of efficacy and acceptability
24. SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability
25. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Meta-regression analysis
26. Systematic review and guide to selection of selective serotonin reuptake inhibitors
27. Meta-analysis: Reconciling the results of independent studies
28. Fluoxetine and suicide: A meta-analysis of controlled trials of treatment for depression
29. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
30. Sensitivity analysis and diagnostics